Read Taconic's response to coronavirus (COVID-19), and visit our toolkit for researchers. Learn More

Gabra2 - Model 6508 - KO

Constitutive Knockout

Cryopreserved Model
This line is cryopreserved and requires cryorecovery.

  • Model #
  • Genotype
  • Nomenclature
  • 6508
    B6;129S6-Gabra2t31.2 dns
  • The targeting vector has been generated using 129SvEv DNA and transfected into 129SvEv ES cell line.
  • Gabra2 exon 4 was deleted by the neomycin resistance cassette, which is flanked by loxP sites.
  • Chimeric mice were produced and germ line transmission achieved.
  • The neomycin resistance gene has not been deleted in the constitutive KO mice.
  • Deletion of exon 4 should result in loss of function of the Gabra2 gene by deleting functional domains of the protein.
  • Gabra2 constitutive KO mice are in a mixed C57BL/6-129SvEv genetic background.
  • See C.I. Dixon et al, Pharmacology, Biochemistry and Behavior 90, 1-8, 2008, for further details.

Gene Family:

Receptor

Genetic Background:

C57BL/6;129SvEv

Gene Accession Number:

NM_008066

Allele Type:

KO

Source:

Merck Research Laboratories

Availability:

Cryopreserved at Taconic

Species:

Mouse

Official Gene Name:

gamma-aminobutyric acid (GABA) A receptor, subunit alpha 2

Customers may purchase this model by signing the appropriate Terms of Sale (below) and providing a PO. The GEM Collection Commercial and Academic Terms of Sale grant perpetual use rights.
GEM Collection models exist as cryopreserved materials. Models can typically be recovered and delivered to customers within 14-16 weeks after order receipt. Customers will receive:

  • A minimum of four (4) mice heterozygous for the selected mutation. In rare cases where the cryopreserved material also contains a recombinase gene, this may be reduced to 1-2 heterozygous mice.
  • Validated genotyping protocols
  • Animal health report. Mice will meet Taconic's Murine Pathogen Free™ (MPF™) health standard.

Please note that in rare instances (2%) cryorecovery may prove to be difficult, either extending timeline or ultimately successful recovery.

For-Profit Pricing:

Price per Line ($)
$30,000

Non-Profit Pricing:

Price per Line ($)
$5,500

For-Profit Pricing:

Price per Line (€)
€27,300

Non-Profit Pricing:

Price per Line (€)
€5,005